BASKING RIDGE, N.J. & RAHWAY, N.J.--(BUSINESS WIRE)-- The first patient has been dosed in the HERTHENA-Breast04 phase 3 trial evaluating the efficacy and safety of investigational patritumab ...
Opthea's Phase 3 COAST trial for wet AMD failed its primary endpoint, raising concerns about the company's financial stability. Opthea Limited announced that its global Phase 3 trial, COAST, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback